Liver glucose uptake has been previously shown to be decreased in obesity [6] and type 2 diabetes [5] when compared to lean controls during euglycemic-hyperinsulinemia; this reflects the impaired glucokinase activity, i.e., the rate-limiting step in hepatic glycogen synthesis [37]. The gene discussed is GCK; the disease is obesity due to melanocortin 4 receptor deficiency.